Allscripts
7
47M
5
0.19
2
0.29
3
- Areas of investment
Summary
In 1986 was created Allscripts, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Chicago. The fund was located in North America if to be more exact in United States.
The fund is constantly included in less than 2 deals per year. The average startup value when the investment from Allscripts is more than 1 billion dollars. This Allscripts works on 31 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this Corporate Investor is 0 percentage points less often commits exit comparing to other companies. Deals in the range of 50 - 100 millions dollars are the general things for fund. The important activity for fund was in 2012. The higher amount of exits for fund were in 2013.
The fund was created by Bill Marvin. The overall number of key employees were 2.
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most successful fund investment fields, there are SaaS, Medical. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline NantHealth, Humedica, dbMotion
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Allscripts, startups are often financed by Vertex Ventures Israel, Vertex Ventures, Pitango Venture Capital. The meaningful sponsors for the fund in investment in the same round are Vertex Ventures Israel, Vertex Ventures, UPMC. In the next rounds fund is usually obtained by Vertex Ventures Israel, Vertex Ventures, UPMC.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 2
- Exits
- 3
- Rounds per year
- 0.19
- Follow on index
- 0.29
- Investments by industry
- Health Care (7)
- Analytics (3)
- Information Technology (2)
- Developer Platform (2)
- Biotechnology (2) Show 11 more
- Investments by region
-
- United States (3)
- Israel (2)
- Singapore (2)
- Peak activity year
- 2023
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Avg. valuation at time of investment
- 387M
- Group Appearance index
- 0.71
- Avg. company exit year
- 17
- Avg. multiplicator
- 1.27
- Strategy success index
- 0.10
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Holmusk | 09 Jan 2023 | Biotechnology, Analytics, Health Care, Wellness, Electronic Health Record (EHR), Personal Health, mHealth | Early Stage Venture | 45M | Central, Singapore, Singapore |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.